Stay updated on Comparing Lenvatinib vs Sorafenib in Hepatocellular Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Comparing Lenvatinib vs Sorafenib in Hepatocellular Carcinoma Clinical Trial page.

Latest updates to the Comparing Lenvatinib vs Sorafenib in Hepatocellular Carcinoma Clinical Trial page
- Check4 days agoChange DetectedPage revision updated from v3.5.3 to v3.5.4, indicating a new build of the site. This update appears to be a backend or packaging change with no visible edits to study information or the page’s user-facing content.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check19 days agoChange DetectedTaoyuan City, Taiwan has been added to the list of study locations, and Taoyuan, Taiwan has been removed. This change refines the location entry to reflect the correct municipal designation for the site.SummaryDifference0.0%

- Check26 days agoChange DetectedThe page’s footer “Revision” version has been updated from v3.5.2 to v3.5.3, indicating a website release/version change rather than an update to the clinical trial information.SummaryDifference0.0%

- Check33 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed.SummaryDifference0.0%

- Check40 days agoChange DetectedNo substantive changes to the page content were detected. The study overview, design, eligibility criteria, and outcomes remain as shown.SummaryDifference0.0%

- Check55 days agoChange DetectedNaples, Italy has been added as a location. Napoli, Italy has been removed.SummaryDifference0.0%

Stay in the know with updates to Comparing Lenvatinib vs Sorafenib in Hepatocellular Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparing Lenvatinib vs Sorafenib in Hepatocellular Carcinoma Clinical Trial page.